AZN

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Astrazeneca plc - ADR

CEO
Pascal Soriot
Employees
76100
Headquarters

1 Francis Crick Avenue
Cambridge, Cambridgeshire CB2 0AA
Phone: 11442073045000
https://www.astrazeneca.com/home

News

The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
Jul 15, 2024 14:51pm

As good as the S&P 500 is performing in 2024, the Nasdaq 100 is doing even better. The tech-oriented index is up 23% this year, compared to an 19% gain by the benchmark index. It’s not surprising the Nasdaq is doing so well. Because it is a modified market cap-weighted index, bigger companies have a larger impact on its performance. The biggest six stocks are all worth more than $1 trillion dollars, and Tesla (NASDAQ: TSLA ) the seventh largest, is within striking distance at just under $900 billion. That means the Magnificent Seven stocks from last year all have an outsized say in how well the index is doing this year. Considering all but the electric vehicle manufacturer are up by double-digit percentages — in fact, they are up by 20% or more — it may be more remarkable that the Nasdaq 100 isn’t up even more. It also means finding undervalued Nasdaq 100 stocks isn’t easy. Some 60% of all index components are in the green but not all are doing better than the index itself. With only a quarter of the components doing as well or better, it suggests there are still quite a few discounted stocks to buy.


Source:InvestorPlace
Cultivating a Culture of Excellence: AstraZeneca’s Commitment to Innovation, Positive Workplace Environment
Jul 15, 2024 14:36pm

In Bryanston, South Africa, a group of passionate scientists and healthcare professionals gather at AstraZeneca’s South African office. The purpose; to advance groundbreaking health tech innovations aimed at improving health outcomes across the world. For many of these individuals, AstraZeneca is more than just a workplace; it’s a second home where their ideas are refined, […] The post Cultivating a Culture of Excellence: AstraZeneca’s Commitment to Innovation, Positive Workplace Environment appeared first on Tech | Business | Economy .


Source:TechEconomy
Cultivating a Culture of Excellence: AstraZeneca’s Commitment to Innovation and Positive Workplace Environment
Jul 15, 2024 14:01pm

In Bryanston, South Africa, a group of passionate scientists and healthcare professionals gather at AstraZeneca’s South African office. The purpose; to advance groundbreaking health tech innovations aimed at improving health outcomes across the world. For many of these individuals, AstraZeneca is more than just a workplace; it’s a second home where their ideas are refined, […] The post Cultivating a Culture of Excellence: AstraZeneca’s Commitment to Innovation and Positive Workplace Environment appeared first on ITPulse.com.ng .


Source:ITPulse
EQS-News: Andera Partners'' portfolio company Amolyt Pharma completes acquisition by AstraZeneca
Jul 15, 2024 07:31am

EQS-News: Andera Partners / Key word(s): Mergers & Acquisitions/Private Equity Andera Partners'' portfolio company Amolyt Pharma completes acquisition by AstraZeneca 15.07.2024 / 09:30 CET/CEST The…


Source:Finanz Nachrichten
EQS-News: Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca
Jul 15, 2024 07:30am

EQS-News: Andera Partners / Key word(s): Mergers & Acquisitions/Private Equity Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca 15.07.2024 / 09:30 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
AstraZeneca in billion-dollar swoop
Jul 15, 2024 07:04am

… French MedTech Amolyt Pharma . Amolyt Pharma is a clinical- … The acquisition bolsters Alexion, AstraZeneca ’s rare disease late- … agreement, AstraZeneca has acquired all of Amolyt Pharma ’s outstanding … build digital backbone for pharma ’ It could benefit patients …


Source:EIN News Pharmaceuticals
AstraZeneca Plc completes acquisition of Amolyt Pharma
Jul 15, 2024 06:16am

AstraZeneca plc (LON: AZN) has completed the acquisition of Amolyt Pharma, enhancing its rare disease pipeline and expanding its bone metabolism franchise.


Source:DirectorsTalk
UN alarmed as childhood immunisation levels stall
Jul 15, 2024 06:15am

GENEVA: Global childhood vaccination levels have stalled, leaving millions more children un- or under-vaccinated than before the pandemic, the UN said Monday, warning of dangerous coverage gaps enabling outbreaks of diseases like measles. In 2023, 84 percent of children, or 108 million, received three doses of the vaccine against diphtheria, tetanus and pertussis (DTP), with the third dose serving as a key marker for global immunisation coverage, according to data published by the UN health and children’s agencies. That was the same percentage as a year earlier, meaning that modest progress seen in 2022 after the steep drop during the Covid-19 crisis has “stalled”, the organisations warned. The rate was 86 percent in 2019 before the pandemic. “The latest trends demonstrate that many countries continue to miss far too many children,” UNICEF chief Catherine Russell said in a joint statement. Intending pilgrims advised to ensure vaccination In fact, 2.7 million additional children remained un- or under-vaccinated last year compared to the pre-pandemic levels in 2019, the organisations found. ‘Off track’ “We are off track,” World Health Organization vaccine chief Kate O’Brien told reporters. “Global immunisation coverage has yet to fully recover from the historic backsliding that we saw during the course of the pandemic.” Not only has progress stalled, but the number of so-called zero-dose children, who have not received a single jab, rose to 14.5 million last year from 13.9 million in 2022 and from 12.8 million in 2019, according to the data published Monday. “This puts the lives of the most vulnerable children at risk,” O’Brien warned.


Source:Business Recorder
Is AstraZeneca Stock (NASDAQ:AZN) Overbought or Worth the Valuation?
Jul 11, 2024 23:23pm

AstraZeneca (NASDAQ:AZN) (LSE:AZN) trades at a premium to most of its big-pharma peers, with the exception of weight-loss giants Eli Lilly (NYSE:LL…


Source:TipRanks
Instil Bio inks 15-year lease with AstraZeneca
Jul 11, 2024 21:12pm

https://www.investing.com/news/company-news/instil-bio-inks-15year-lease-with-astrazeneca-93CH-3516458


Source:Investing.com